NCT05245916 2023-09-05IBI397 or Combination Therapies in Patients With Advanced MalignanciesInnovent Biologics (Suzhou) Co. Ltd.Phase 1 Withdrawn
NCT02520245 2016-11-07Companion Study for Patients Who Completed Participation in a REGN2810 (Anti-PD-1) Clinical StudyRegeneron PharmaceuticalsPhase 1 Withdrawn